Mr. ROSHAN KUMAR | Materials Chemistry | Best Researcher Award

Published on by Chemistry Awards

Mr. ROSHAN KUMAR | Materials Chemistry | Best Researcher Award

Mr. ROSHAN KUMAR , Materials Chemistry , Senior Scientist at CSIR – National Metallurgical Laboratory, India

Dr. Roshan Kumar is a highly accomplished Senior Scientist at CSIR–National Metallurgical Laboratory, Jamshedpur. With an academic foundation from premier institutes like IIT Delhi and NIT Jamshedpur, he brings over a decade of research and industrial experience in materials science, mechanical design, and manufacturing. His expertise spans from engine integration design at Tata Motors to pioneering research in biodegradable implants, hydrogen energy, and advanced metallurgy at CSIR-NML. He is actively involved in national research projects including DRDO, DST, and CSIR initiatives. Known for his innovative thinking and multidisciplinary research capabilities, he has significantly contributed to the development of green hydrogen solutions and advanced manufacturing processes. Dr. Kumar is also a passionate advocate for technology-driven social change, participating in programs like Women Technology Park. With multiple publications in reputed international journals and awards to his credit, he continues to bridge academic excellence and applied engineering for societal advancement.

Professional Profile : 

Scopus 

Summary of Suitability for Award:

Dr. Roshan Kumar exemplifies the qualities of an outstanding researcher, with a strong academic background from premier institutions like IIT Delhi and NIT Jamshedpur, and over a decade of professional experience across industry and research. Currently a Senior Scientist at CSIR–National Metallurgical Laboratory, he has made significant contributions to materials research, particularly in biodegradable implants, hydrogen energy, computational modeling, and metal corrosion studies. His work bridges computational science with experimental materials design, reflecting innovation and societal relevance. Recognized with an All India Rank 3 in CSIR-NET and a Best Poster Award at an international hydrogen conference, he has authored impactful publications in high-ranking journals. His leadership in interdisciplinary CSIR and DST projects underscores his collaborative and forward-looking research approach. With a clear focus on materials science and clean energy, Dr. Kumar’s achievements demonstrate excellence, innovation, and real-world application. Dr. Roshan Kumar is highly suitable for the “Best Researcher Award”, given his exemplary track record in research innovation, publication impact, national-level project leadership, and meaningful contributions to sustainable and advanced technologies.

🎓Education:

Dr. Roshan Kumar’s educational journey showcases academic brilliance and technical depth. He earned his M.Tech in Design Engineering from Indian Institute of Technology (IIT) Delhi in 2015 with an impressive CGPA of 9.115, demonstrating strong command in mechanical design and computational engineering. He completed his B.Tech in Production Engineering and Management from NIT Jamshedpur in 2010, securing a GPA of 8.65, laying a robust foundation in manufacturing and production systems. His schooling reflects consistent academic performance with 72% in CBSE (2005) from VBCV, Jamshedpur, and 69.2% in Class X (2003) under the Jharkhand Board from SJS, Jamshedpur. His early academic achievements were further validated by an All India Rank 3 in CSIR-NET, earning him eligibility for the prestigious Shyama Prasad Mukherjee Fellowship (2013). This strong educational background has fueled his contributions to scientific research, innovation, and national R&D missions.

🏢Work Experience:

Dr. Roshan Kumar currently serves as a Senior Scientist at the Engineering Division of CSIR–NML, Jamshedpur (Dec 2019 – Present), where he leads and contributes to projects involving materials science, hydrogen energy, and biodegradable implants. Before joining CSIR, he worked as a Senior Manager at Tata Motors Limited (Sept 2015 – Nov 2019) in the Engine Integration Design department at the Engineering Research Centre, Jamshedpur. His role involved design validation, component analysis, and optimization in automotive engineering. Earlier, he began his career at Mahindra and Mahindra Limited (July 2010 – June 2011) as a Graduate Apprentice Trainee in the Engine Department at Rudrapur. Across these roles, Dr. Kumar has built a strong reputation in integrating academic research with industrial applications, especially in engine systems, manufacturing technology, and metallurgical engineering. His experience spans both applied research and industrial innovation, making him a valuable contributor to national science missions.

🏅Awards: 

Dr. Roshan Kumar has received notable recognition for his research excellence and academic accomplishments. He secured an All India Rank 3 in the CSIR-NET Examination, qualifying him for the Shyama Prasad Mukherjee Fellowship in 2013, one of the most prestigious fellowships for young researchers in India. In 2023, he was honored with the Best Poster Award at the 1st International Conference on Green Hydrogen for Global De-carbonization, recognizing his innovative work in clean energy research. His award-winning contributions span materials design, hydrogen generation, and advanced manufacturing. Additionally, his work is frequently cited and featured in reputed international journals, establishing his scholarly impact. These accolades highlight his dedication to solving global engineering challenges and his capacity to influence cutting-edge research in sustainable technologies, materials development, and design engineering. His involvement in national-level projects and active membership in multiple CSIR initiatives further solidify his reputation as a leading researcher in his field.

🔬Research Focus:

Dr. Roshan Kumar’s research is focused on materials engineering, design optimization, and clean energy technologies, with a keen interest in sustainable manufacturing. His key contributions include the development of biodegradable Mg/Zn-based implants, atomic-scale corrosion studies, and hydrogen generation through metal–water reactions. At CSIR–NML, he has led and co-led projects on machinability of Mg alloys, electroplating systems for medical applications, and weldability of high-strength steels in collaboration with DRDO and Tata Steel. His work blends computational simulations, molecular dynamics, and experimental validations to explore fracture toughness, fatigue behavior, and additive manufacturing processes. He also contributes to the CSIR Integrated Skill Training and Phenome India Health Cohort initiatives. His interdisciplinary approach leverages simulation, materials science, and product design to create real-world engineering solutions. Dr. Kumar’s work plays a pivotal role in India’s R&D landscape, especially in advancing green hydrogen energy, smart materials, and medical-grade alloys.

Publication Top Notes:

1. Atomic Investigation of Corrosion Mechanism and Surface Degradation of Fe–Cr–Ni Alloy in Presence of Water: Advanced Reactive Molecular Dynamics Simulation

Citations: 2

2. Atomistic Characterization of Multi Nano‑Crystal Formation Process in Fe–Cr–Ni Alloy During Directional Solidification: Perspective to the Additive Manufacturing

 

 

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Published on by Chemistry Awards

Assist. Prof. Dr. Changtong YANG | Medicinal Chemistry | Best Researcher Award

Assist. Prof. Dr. Changtong YANG , Medicinal Chemistry,  Radiochemist/Chemist at Singapore General Hospital, Singapore

Dr. Chang-Tong Yang is a renowned radiochemist based in Singapore, specializing in radiopharmaceuticals and molecular imaging. He currently serves as an Assistant Professor in the Radiological Science Academic Clinical Programme at Duke-NUS Medical School and as a Radiochemist at Singapore General Hospital. With over two decades of experience, Dr. Yang has made significant contributions to the development of nuclear imaging probes and radiolabeled therapeutics. His research career spans prestigious institutions, including Nanyang Technological University and A*STAR. Dr. Yang is internationally recognized for advancing nanomaterial probes and novel radiolabeling strategies. He has authored impactful publications in top-tier journals, reflecting his innovation in theranostics, radiochemistry, and nanomedicine. With a strong background in academic and clinical research, Dr. Yang continues to shape the future of molecular imaging for personalized medicine. His global education and interdisciplinary expertise make him a leading figure in translational radiochemistry research.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Chang-Tong Yang exemplifies the qualities of a “Best Researcher Award” recipient. His innovative contributions to radiochemistry and molecular imaging, combined with a strong publication record, interdisciplinary leadership, and global training, establish him as a trailblazer in translational medical research. His work is not only scientifically rigorous but also clinically impactful, directly advancing the field of nuclear medicine. Therefore, he is highly recommended for recognition as a top-tier researcher deserving of this award.

🎓Education:

Dr. Chang-Tong Yang received his Ph.D. in Chemistry from the National University of Singapore (1998–2002), where he laid the foundation for his career in radiochemistry. He further enhanced his expertise with postdoctoral fellowships at three prestigious U.S. institutions: University of Iowa (2003–2005), University of Michigan (2005–2006), and Purdue University (2006–2007), focusing on chemistry and health sciences. These formative years provided Dr. Yang with a multidisciplinary perspective in synthetic chemistry, radiopharmaceutical development, and imaging sciences. His international training exposed him to cutting-edge methodologies and collaborative projects across biomedical research, which he has since translated into innovative imaging solutions. The combination of rigorous education and hands-on research across these top institutions shaped his ability to bridge fundamental science with clinical applications, particularly in nuclear medicine and molecular imaging.

🏢Work Experience:

Dr. Chang-Tong Yang brings extensive professional experience across both academic and clinical research settings. He is currently an Assistant Professor at Duke-NUS Medical School (2020–present) under the Radiological Science ACP, focusing on radiopharmaceutical sciences. Concurrently, he serves as a Radiochemist at Singapore General Hospital (2018–present) in the Department of Nuclear Medicine & Molecular Imaging, where he translates research into clinical practice. Prior to that, he worked as a Senior Scientist at Nanyang Technological University (2014–2018), contributing to molecular imaging initiatives within the Lee Kong Chian School of Medicine. He also held a Senior Scientist role at A*STAR’s Singapore Bio-Imaging Consortium (2007–2014), leading various radiochemistry research programs. Across these roles, Dr. Yang has developed and validated imaging agents, optimized radiolabeling techniques, and led translational studies that impact diagnostic imaging and therapeutic strategies. His multidisciplinary engagements underscore his pivotal role in bridging chemistry and medicine.

🏅Awards: 

While specific awards are not listed in the available data, Dr. Chang-Tong Yang’s extensive contributions to radiopharmaceuticals and molecular imaging reflect a highly respected and impactful career. His appointments at top institutions such as Duke-NUS, A*STAR, and Singapore General Hospital indicate peer recognition and institutional trust. His publications in reputed journals such as Molecules, Nanomaterials, and Drug Discovery Today highlight his standing in the scientific community. His ongoing leadership roles and collaboration with clinicians further underscore professional acknowledgment of his expertise. Dr. Yang’s selection for multiple postdoctoral positions at prestigious U.S. institutions—University of Iowa, University of Michigan, and Purdue University—suggests early recognition of his academic promise. His interdisciplinary contributions to nuclear medicine, nanotechnology, and molecular imaging may have earned him internal institutional awards, research grants, and invitations to present at scientific forums, which commonly accompany such roles.

🔬Research Focus:

Dr. Chang-Tong Yang’s research is centered on radiopharmaceutical science, with a strong emphasis on the development of molecular imaging probes and radiolabeled nanomaterials for diagnostic and therapeutic applications. His expertise lies in designing novel radioisotope-labeled compounds for use in nuclear medicine imaging techniques such as PET and SPECT, targeting cancer and other pathological conditions. He is particularly interested in enhancing the in vivo behavior of nanomaterial-based agents, improving tumor targeting, retention, and safety. Dr. Yang also explores the biocompatibility and stability of these probes, including how formulation and labeling protocols influence their function. His translational work bridges laboratory innovations with clinical imaging requirements, enabling personalized diagnostics and theranostic approaches. Furthermore, he investigates radiochemical compatibility in clinical settings, such as the mixing of imaging agents with contrast media, which supports safe and effective imaging protocols. His work integrates chemistry, imaging, and clinical practice seamlessly.

Publication Top Notes:

1. pH-Induced In Situ Aggregation of Cu₂₋ₓSe-POED with Extended Tumor Retention for Enhanced Chemodynamic/Photothermal Therapy

2. Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes

3. Radiolabeled Liposomes for Nuclear Imaging Probes

4. Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast

5. Nanomaterial Probes for Nuclear Imaging

6. Positron Emission Tomographic Imaging in Drug Discovery

7. An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C]PBR28 and [18F]flumazenil PET Imaging

8. Gadolinium-Based Bimodal Probes to Enhance T1-Weighted Magnetic Resonance/Optical Imaging

9. Activatable Cell-Penetrating Peptide Conjugated Polymeric Nanoparticles with Gd-Chelation and Aggregation-Induced Emission for Bimodal MR and Fluorescence Imaging of Tumors

10. Dealing with PET Radiometabolites

11. PET-MR and SPECT-MR Multimodality Probes